Feedback / Questions
AZD8835 - AstraZeneca
AZN terminates multiple oncology pipeline drugs
-
Apr 30, 2016 -
"Terminations: AZD8835 - Area under investigation: solid tumours; Reason for discontinuation: Safety/efficacy."
Discontinued
•
Oncology
https://twitter.com/nixon786/status/726589134177984512
Apr 30, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious